Reporting owner · Q3 2026 · CIK 1813798

Wassil Jim: insider trades.

Wassil Jim reported 17 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 11 sales ($624K), across 1 company.

Transactions
17
Purchases (P)
0
Sales (S)
11
Companies
1
Name as filed
Wassil Jim

Companies

CompanyRelationshipTransactions
Vaxcyte, Inc. (PCVX)Officer · EVP, Chief Scientific Ofc, COO17

Transactions

17 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-09Vaxcyte, Inc.S1,334$59.52145,435Form 4
2026-09-08Vaxcyte, Inc.F5,459$60.36146,769Form 4
2026-09-04Vaxcyte, Inc.S1,381$61.16152,228Form 4
2026-09-02Vaxcyte, Inc.F1,432$61.58153,609Form 4
2026-09-01Vaxcyte, Inc.S303$61.42155,041Form 4
2026-09-01Vaxcyte, Inc.M2,250$5.35158,518Form 4
2026-09-01Vaxcyte, Inc.S1,537$60.89156,981Form 4
2026-09-01Vaxcyte, Inc.S713$61.48156,268Form 4
2026-09-01Vaxcyte, Inc.S924$60.96155,344Form 4
2026-08-31Vaxcyte, Inc.F1,273$60.74156,268Form 4
2026-08-03Vaxcyte, Inc.M2,250$5.35159,791Form 4
2026-08-03Vaxcyte, Inc.S861$53.5158,930Form 4
2026-08-03Vaxcyte, Inc.S1,389$54.09157,541Form 4
2026-07-01Vaxcyte, Inc.M516$5.35159,010Form 4
2026-07-01Vaxcyte, Inc.S6$57.82156,760Form 4
2026-07-01Vaxcyte, Inc.S456$57.47156,766Form 4
2026-07-01Vaxcyte, Inc.S1,788$56.03157,222Form 4

Questions

What stock did Wassil Jim buy or sell?

Wassil Jim reported 17 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 11 sales ($624K), across 1 company.

Is Wassil Jim the same person as other filers with this name?

This page covers SEC CIK 1813798 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/wassil-jim-1813798.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.